Last update 29 Aug 2025
Institute of Radiology, Chinese Academy of Medical Sciences

Institute of Radiology, Chinese Academy of Medical Sciences

Education|Tianjin Shi, China

Overview

Tags

Neoplasms
Immune System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug3
Top 5 TargetCount
WDHD1(WD repeat and HMG-box DNA binding protein 1)1
PARP1(Poly (ADP-Ribose) polymerase 1)1
IL-1β x NLRP31

Related

3
Drugs associated with Institute of Radiology, Chinese Academy of Medical Sciences
H52
Target
PARP1
Mechanism
PARP1 inhibitors
Active Org.
Institute of Radiology, Chinese Academy of Medical SciencesInstitute of Radiology, Chinese Academy of Medical Sciences
Originator Org.
Institute of Radiology, Chinese Academy of Medical SciencesInstitute of Radiology, Chinese Academy of Medical Sciences
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
WO2023025264
Patent Mining
Target
IL-1β x NLRP3
Mechanism
IL-1β inhibitors [+1]
Active Org.
Institute of Radiology, Chinese Academy of Medical SciencesInstitute of Radiology, Chinese Academy of Medical Sciences [+1]
Originator Org.
Institute of Radiology, Chinese Academy of Medical SciencesInstitute of Radiology, Chinese Academy of Medical Sciences [+1]
Active Indication
Autoimmune Diseases
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
CN117510350
Patent Mining
Target
WDHD1
Mechanism-
Active Org.
Institute of Radiology, Chinese Academy of Medical SciencesInstitute of Radiology, Chinese Academy of Medical Sciences
Originator Org.
Institute of Radiology, Chinese Academy of Medical SciencesInstitute of Radiology, Chinese Academy of Medical Sciences
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Institute of Radiology, Chinese Academy of Medical Sciences
Login to view more data
0 Patents (Medical) associated with Institute of Radiology, Chinese Academy of Medical Sciences
Login to view more data
100 Deals associated with Institute of Radiology, Chinese Academy of Medical Sciences
Login to view more data
100 Translational Medicine associated with Institute of Radiology, Chinese Academy of Medical Sciences
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Mar 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
1
Preclinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
H52
 ( PARP1 )		Neoplasms
More
Preclinical
CN117510350
 ( WDHD1 )Patent Mining		Neoplasms
More
Discovery
WO2023025264
 ( IL-1β x NLRP3 )Patent Mining		Autoimmune Diseases
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free